Efficiency of an Optimized Care Organization for Fatigue Management for Patients With COVID-19.
NCT05236478 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17
Last updated 2022-03-02
Summary
Length of hospitalization for COVID-19 infection may be increased due to the persistence of fatigue in 29-46% of cases. Its management is essential to prevent the chronic fatigue . Chronic fatigue syndrome affected between 30 and 40% of patients with SARS in 2003 or MERS in 2005 and persisted beyond 3 years. There is currently no specific treatment for acute or \<4 months asthenia. To avoid the transition to chronicity, some authors recommend respecting a long rest period. However, a program combining adapted physical activity and therapeutic patient education has already shown significant benefits for combating recent or semi-recent fatigue following a cardiovascular pathology and even during cancer treatments. Therefore, the existing care pathway for hospitalized patients with COVID-19 was adapted, combining exercise training and therapeutic patient education workshops.
Conditions
Interventions
- OTHER
-
CoviMouv' program
* An initiation to physical rehabilitation at the hospital center the first week, 3 sessions of 1 hour. * A tele-rehabilitation program led by an Adapted Physical Activity (APA) teacher for 3 weeks with 3 sessions of 1 hour per week. All the sessions are led by a professional of adapted physical activity and will be personalized and adapted to the functional tests carried out during the initial evaluation. * Therapeutic education video-workshops weekly: about (i) the pathophysiology of fatigue in COVID-19, (ii) returning to work, (iii) lifestyle: sleep, physical activity and diet. * The medical follow-up will be carried out remotely with 1 weekly teleconsultation with a physiologist. * Psychological and / or dietetic follow-up, if necessary, during the program: 1 weekly teleconsultation At the end of the program, each participant is invited to contact the sport-health platform in order to continue the Adapted Physical Activity (APA) practice near home for 2 months.
- OTHER
-
Control
The CoviMouv' program is not presented to theses patients They have support for the resumption of an adapted physical activity in autonomy, according to the results of the aerobic and anaerobic tests carried out during the initial evaluation (delivery of a training booklet).
Sponsors & Collaborators
-
Centre Hospitalier Universitaire de Saint Etienne
lead OTHER
Principal Investigators
-
David HUPIN, MD · CHU SAINT-ETIENNE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-02-01
- Primary Completion
- 2021-07-31
- Completion
- 2021-07-31
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2
NCT04337424 ·Status: COMPLETED
-
Risk Factors Worsening COVID19 for Out-patient With Home Monitoring
NCT04380662 ·Status: UNKNOWN
-
Study to Investigate the Efficacy of Abrocitinib in Adult Participants With Severe Fatigue From Post COVID Condition/Long COVID
NCT06597396 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pulmonary Function in Patients Recovering From COVID19 Infection : a Pilot Study
NCT05074927 ·Status: UNKNOWN ·Phase: NA
-
Multimodal Long Covid19
NCT05932797 ·Status: UNKNOWN ·Phase: NA
-
Role of the Microbiota in the Evolution of the SARS-CoV-2 Disease,COVID-19, in Hospitalized Patients
NCT04669938 ·Status: UNKNOWN
-
Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors
NCT05610436 ·Status: RECRUITING
-
Clinical Characteristics And Outcome Of COVID-19 Infection In Patients With Chronic Respiratory Diseases.
NCT05054127 ·Status: UNKNOWN
-
Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19
NCT06142279 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical, Virological, Serological and Immunological Characteristics During and Following COVID-19 Hospitalization
NCT05274373 ·Status: UNKNOWN
-
A Retrospective Study in Patients With Mild to Moderate COVID-19
NCT05374772 ·Status: UNKNOWN
-
COVID-19 : Pulmonary Ultrasound in Primary Care
NCT05226403 ·Status: COMPLETED
-
Covid-19 Long-term Revalidation Follow-up
NCT04685629 ·Status: WITHDRAWN
-
Follow-up of Patients With Previous SARS-CoV-2 Infection: Long-term Damage Assessment
NCT05359159 ·Status: RECRUITING
-
Long-term Effects of COVID-19: a Comparative Cohort Study
NCT05002205 ·Status: UNKNOWN
-
Recovery of Respiratory System in COVID-19 Patients
NCT04954222 ·Status: COMPLETED
-
Optimization of Patients Long-term Management After the Coronavirus Infection COVID-19
NCT04871789 ·Status: UNKNOWN
-
Follow-up of Respiratory Sequelae of Hospitalized Patients With COVID-19
NCT04505631 ·Status: COMPLETED
-
Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients
NCT04324047 ·Status: UNKNOWN
-
Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry
NCT04347278 ·Status: UNKNOWN
-
Study of COVID-19 Prognostic Factors in Hospitalized Patients
NCT05102708 ·Status: COMPLETED
-
COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients
NCT05587868 ·Status: UNKNOWN
-
Bevacizumab in Post-acute Sequelae of COVID-19 : Efficacy and Safety (Pilot Study)
NCT07089719 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comorbidities and Risk Score in COVID-19 Patients
NCT04670094 ·Status: COMPLETED
-
Microecology and Host Immunity in Patients With Severe COVID-19 Infection
NCT05670275 ·Status: UNKNOWN